share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股sec公告 ·  06/04 17:08
Moomoo AI 已提取核心訊息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on May 31, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the provided announcement. The action reflects a change in Bourla's holdings in the company, but without additional information, the impact on his total number of shares held after the action cannot be determined.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on May 31, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the provided announcement. The action reflects a change in Bourla's holdings in the company, but without additional information, the impact on his total number of shares held after the action cannot be determined.
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布拉於 2024 年 5 月 31 日完成非衍生品證券交易。該交易的具體詳情,包括股份數量、交易價格和總價值,並未在提供的公告中披露。該行動反映了 Bourla 在該公司持股的變化,但沒有其他信息,則無法確定他在該行動後持有的股份總數的影響。
輝瑞公司(PFE)董事長兼首席執行官阿爾伯特·布拉於 2024 年 5 月 31 日完成非衍生品證券交易。該交易的具體詳情,包括股份數量、交易價格和總價值,並未在提供的公告中披露。該行動反映了 Bourla 在該公司持股的變化,但沒有其他信息,則無法確定他在該行動後持有的股份總數的影響。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息